Neoplasms

Connect

Letters 4 Oct 2021

Australian recommendations for the management of hepatocellular carcinoma

Alain Braillon

Med J Aust 2021; 215 (7): 334-334.e1

Letters 4 Oct 2021

Australian recommendations for the management of hepatocellular carcinoma

John S Lubel, Stuart K Roberts, Simone I Strasser and Nick Shackel

Med J Aust 2021; 215 (7): 334-334.e1

Narrative review 4 Oct 2021

Evaluation and management of rectal bleeding in pregnancy

Ralley Prentice, Aysha Al‐Ani, Tiffany Cherry, Julia Dixon‐Douglas, Jade Eccles‐Smith, Julia Matheson, Jeanne Tie, Iniyaval Thevathasan, Jacob J McCormick and Britt Christensen

Med J Aust 2021; 215 (8): 377-382

Research letter 13 Sep 2021

The clinical value of “exception item” colonoscopy (MBS item 32228)

Michelle Lee See, Antonio Lee, Roderick Roberts, Richard A Friedman, David G Hewett and Daniel L Worthley

Med J Aust 2022; 216 (2): 94-95 Free

Research 13 Sep 2021

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations

Tamara Hettipathirana, Courtney Macdonald, Jing Xie, Kate Moodie, Chris Michael and Kelly‐Anne Phillips

Med J Aust 2021; 215 (10): 460-464 Free

Editorials 6 Sep 2021

Excessive PSA testing in general practice

Justin J Coleman

Med J Aust 2021; 215 (5): 215-216

Research 30 Aug 2021

The influence of the surveillance time interval on the risk of advanced neoplasia after non‐advanced adenoma removal

Zaki Hamarneh, Charles Cock, Graeme P Young, Peter A Bampton, Robert Fraser, Fang LI Ang, Feruza Kholmurodova and Erin L Symonds

Med J Aust 2021; 215 (10): 465-470 Free

Research 23 Aug 2021

Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk‐stratified population screening

Naomi Noguchi, Michael L Marinovich, Elizabeth J Wylie, Helen G Lund and Nehmat Houssami

Med J Aust 2021; 215 (8): 359-365 Free

Editorial 19 Jul 2021

Non‐alcoholic fatty liver disease: raising awareness of a looming public health problem

Lucy Gracen and Elizabeth E Powell

Med J Aust 2021; 215 (2): 75-76

Letters 19 Jul 2021

Rethinking cancer survivorship: the Prostate Cancer Survivorship Essentials Framework

Jeff Dunn, Bogda Koczwara and Suzanne Chambers

Med J Aust 2021; 215 (2): 94-94.e1 Free

Research 28 Jun 2021

Self‐collection cervical screening in the renewed National Cervical Screening Program: a qualitative study

Nicola S Creagh, Claire Zammit, Julia ML Brotherton, Marion Saville, Tracey McDermott, Claire Nightingale and Margaret Kelaher

Med J Aust 2021; 215 (8): 354-358 Free

Perspectives 7 Jun 2021

Improving recruitment to clinical trials for regional and rural cancer patients through a regionally based clinical trials network

Arun Muthusamy, Donna Long and Craig R Underhill

Med J Aust 2021; 214 (10): 453-454.e1

Medical education / Snapshot 7 Jun 2021

Cystic and cavitating lung lesions as a presenting finding of metastatic prostate cancer

Michael A Cilento and Christopher M Hocking

Med J Aust 2021; 214 (10): 459-459.e1

Letters 7 Jun 2021

Differences in treatment choices for localised prostate cancer diagnosed in private and public health services

Henry H Woo and Declan G Murphy

Med J Aust 2021; 214 (10): 486-486.e1

Letters 7 Jun 2021

Differences in treatment choices for localised prostate cancer diagnosed in private and public health services

Luc te Marvelde, Roger L Milne and Ian E Haines

Med J Aust 2021; 214 (10): 486-486.e1

Consensus statement summary 31 May 2021

Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards

Eva Segelov, Christine Carrington, Sanchia Aranda, David Currow, John R Zalcberg, Alexander G Heriot, Linda Mileshkin, John Coutsouvelis, Jeremy L Millar, Brian T Collopy, Jon D Emery, Phoebe Zhang, Simon Cooper, Carmel O’Kane, Janet Wale, Stephen J Hancock, Anthony Sulkowski and John Bashford

Med J Aust 2021; 214 (11): 528-531

Perspectives 17 May 2021